Psyence Biomedical Statistics
Total Valuation
PBM has a market cap or net worth of $1.38 million. The enterprise value is -$4.76 million.
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025, before market open.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PBM has 583,263 shares outstanding. The number of shares has increased by 122.15% in one year.
| Current Share Class | 583,263 |
| Shares Outstanding | 583,263 |
| Shares Change (YoY) | +122.15% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 53.66% |
| Float | 543,613 |
Valuation Ratios
The trailing PE ratio is 0.06.
| PE Ratio | 0.06 |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.03 |
| P/TBV Ratio | 0.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.04
| Current Ratio | 11.04 |
| Quick Ratio | 10.55 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -395.15 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -54.20% |
| Return on Invested Capital (ROIC) | -73.88% |
| Return on Capital Employed (ROCE) | -54.49% |
| Revenue Per Employee | n/a |
| Profits Per Employee | $84,316 |
| Employee Count | 12 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.33% in the last 52 weeks. The beta is 0.23, so PBM's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | -99.33% |
| 50-Day Moving Average | 5.42 |
| 200-Day Moving Average | 14.75 |
| Relative Strength Index (RSI) | 35.17 |
| Average Volume (20 Days) | 2,021,026 |
Short Selling Information
The latest short interest is 12,872, so 2.21% of the outstanding shares have been sold short.
| Short Interest | 12,872 |
| Short Previous Month | 20,747 |
| Short % of Shares Out | 2.21% |
| Short % of Float | 2.37% |
| Short Ratio (days to cover) | 0.28 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.66M |
| Pretax Income | -37.27M |
| Net Income | 1.01M |
| EBITDA | -3.66M |
| EBIT | -3.66M |
| Earnings Per Share (EPS) | $41.77 |
Full Income StatementBalance Sheet
The company has $6.14 million in cash and n/a in debt, giving a net cash position of $6.14 million or $10.52 per share.
| Cash & Cash Equivalents | 6.14M |
| Total Debt | n/a |
| Net Cash | 6.14M |
| Net Cash Per Share | $10.52 |
| Equity (Book Value) | 6.72M |
| Book Value Per Share | 94.32 |
| Working Capital | 5.97M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$3.73 million and capital expenditures -$9,877, giving a free cash flow of -$3.74 million.
| Operating Cash Flow | -3.73M |
| Capital Expenditures | -9,877 |
| Free Cash Flow | -3.74M |
| FCF Per Share | -$6.42 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
